Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1937 1
1938 1
1962 4
1963 2
1965 1
1966 1
1974 3
1975 4
1976 5
1977 6
1978 1
1979 3
1980 2
1981 1
1982 3
1985 1
1989 3
1990 1
1992 1
1993 4
1994 1
1995 3
1997 7
1998 2
1999 1
2000 3
2001 1
2002 6
2003 9
2004 9
2005 5
2006 10
2007 7
2008 2
2009 5
2010 23
2011 15
2012 16
2013 25
2014 25
2015 35
2016 23
2017 25
2018 36
2019 36
2020 22
Text availability
Article attribute
Article type
Publication date

Search Results

357 results
Results by year
Filters applied: . Clear all
Page 1
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.
Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD, Dasgupta A, Illies AL, Gebregiworgis T, Dai B, Augustine JJ, Murthy D, Attri KS, Mashadova O, Grandgenett PM, Powers R, Ly QP, Lazenby AJ, Grem JL, Yu F, Matés JM, Asara JM, Kim JW, Hankins JH, Weekes C, Hollingsworth MA, Serkova NJ, Sasson AR, Fleming JB, Oliveto JM, Lyssiotis CA, Cantley LC, Berim L, Singh PK. Shukla SK, et al. Cancer Cell. 2017 Jul 10;32(1):71-87.e7. doi: 10.1016/j.ccell.2017.06.004. Cancer Cell. 2017. PMID: 28697344 Free PMC article.
Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.
Zhang Y, Pitchiaya S, Cieślik M, Niknafs YS, Tien JC, Hosono Y, Iyer MK, Yazdani S, Subramaniam S, Shukla SK, Jiang X, Wang L, Liu TY, Uhl M, Gawronski AR, Qiao Y, Xiao L, Dhanasekaran SM, Juckette KM, Kunju LP, Cao X, Patel U, Batish M, Shukla GC, Paulsen MT, Ljungman M, Jiang H, Mehra R, Backofen R, Sahinalp CS, Freier SM, Watt AT, Guo S, Wei JT, Feng FY, Malik R, Chinnaiyan AM. Zhang Y, et al. Among authors: Shukla SK, Shukla GC. Nat Genet. 2018 Jun;50(6):814-824. doi: 10.1038/s41588-018-0120-1. Epub 2018 May 28. Nat Genet. 2018. PMID: 29808028 Free PMC article.
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.
Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD, Dasgupta A, Illies AL, Gebregiworgis T, Dai B, Augustine JJ, Murthy D, Attri KS, Mashadova O, Grandgenett PM, Powers R, Ly QP, Lazenby AJ, Grem JL, Yu F, Matés JM, Asara JM, Kim JW, Hankins JH, Weekes C, Hollingsworth MA, Serkova NJ, Sasson AR, Fleming JB, Oliveto JM, Lyssiotis CA, Cantley LC, Berim L, Singh PK. Shukla SK, et al. Cancer Cell. 2017 Sep 11;32(3):392. doi: 10.1016/j.ccell.2017.08.008. Cancer Cell. 2017. PMID: 28898700 Free article. No abstract available.
De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer.
Tadros S, Shukla SK, King RJ, Gunda V, Vernucci E, Abrego J, Chaika NV, Yu F, Lazenby AJ, Berim L, Grem J, Sasson AR, Singh PK. Tadros S, et al. Among authors: Shukla SK. Cancer Res. 2017 Oct 15;77(20):5503-5517. doi: 10.1158/0008-5472.CAN-16-3062. Epub 2017 Aug 15. Cancer Res. 2017. PMID: 28811332 Free PMC article.
Proteasome biology and therapeutics in cardiac diseases.
Shukla SK, Rafiq K. Shukla SK, et al. Transl Res. 2019 Mar;205:64-76. doi: 10.1016/j.trsl.2018.09.003. Epub 2018 Sep 28. Transl Res. 2019. PMID: 30342797 Free PMC article. Review.
Pharmacological control of inflammation in wound healing.
Shukla SK, Sharma AK, Gupta V, Yashavarddhan MH. Shukla SK, et al. J Tissue Viability. 2019 Nov;28(4):218-222. doi: 10.1016/j.jtv.2019.09.002. Epub 2019 Sep 14. J Tissue Viability. 2019. PMID: 31542301 Review.
357 results
Jump to page
Feedback